Moreover, downregulation of PKM2 or β-catenin abrogated the IGF-1-induced miR-152 expression, suggesting that miR-152 was involved in a new IGF-1-mediated miR-152/PKM2/β-catenin regulatory circuit in breast cancer. This evidence concerns the gene IGF1 and breast carcinoma.